ASAH1 and cancer: Dysregulation in the expression of SL metabolism enzymes, such as glucosylceramide synthase (GCS), sphingosine kinase and acid ceramidase, leads to cancer cell survival and resistance through drug efflux, bypassing apoptosis or activation of pro-tumorigenic pathways.